NCT00116259View on ClinicalTrials.gov

Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

February 29, 2008

Conditions
Bipolar DisorderAttention Deficit Hyperactivity Disorder
Interventions
DRUG

Aripiprazole

Trial Locations (1)

90035-003

ADHD outpatient program, Porto Alegre - Brazil

All Listed Sponsors
collaborator

Hospital de Clinicas de Porto Alegre

OTHER

lead

Federal University of Rio Grande do Sul

OTHER

NCT00116259 - Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter